YOOR BRIAN B 4
4 · ABBOTT LABORATORIES · Filed Feb 25, 2020
Insider Transaction Report
Form 4
YOOR BRIAN B
Senior Vice President and CFO
Transactions
- Award
Common shares without par value
2020-02-21+14,036→ 128,417 total - Award
Option (right to buy)
2020-02-21+85,562→ 85,562 totalExercise: $87.72From: 2021-02-21Exp: 2030-02-20→ Common shares (85,562 underlying)
Holdings
- 2,248(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2020.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 28,520 on February 21, 2021, 28,521 on February 21, 2022, and 28,521 on February 21, 2023.